# Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections

> **NIH NIH R21** · UNIVERSITY OF MARYLAND BALTIMORE · 2022 · $231,750

## Abstract

PROJECT SUMMARY
Recently, individuals with COVID-19 were found to harbor replicating SARS-CoV-2 inside
salivary epithelial cells resulting in inflammation, architectural distortion, and atrophy of minor
and major salivary glands. We have previously demonstrated the importance of histatin-5, a
secreted salivary antimicrobial peptide exclusively produced in the salivary glands, in protecting
the oral cavity against the opportunistic pathogen Candida albicans. In light of the findings
indicating that COVID-19 patients likely suffer from salivary gland dysfunction, we hypothesize
that histatin-5 salivary levels are compromised in COVID-19 patients potentially predisposing
these individuals to long term opportunistic infections and other oral mucosal conditions. In this
proposed clinical study, we will utilize our developed immunoassay to demonstrate the impact of
COVID-19 on histatin-5 production, Candida colonization, and induction of local immune
activation. We expect the findings generated from these studies to provide lacking mechanistic
insights into the pathophysiology of salivary gland dysfunction in COVID-19 patients, and its
implications on the health of the oral cavity.

## Key facts

- **NIH application ID:** 10429036
- **Project number:** 1R21DE031888-01
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** MARY ANN Y JABRA-RIZK
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $231,750
- **Award type:** 1
- **Project period:** 2022-04-01 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10429036

## Citation

> US National Institutes of Health, RePORTER application 10429036, Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections (1R21DE031888-01). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10429036. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*